This topic contains a solution. Click here to go to the answer

Author Question: The purpose of this initiative was to optimize the product mix and space allocation and thereby ... (Read 38 times)

chads108

  • Hero Member
  • *****
  • Posts: 507
The purpose of this initiative was to optimize the product mix and space allocation and thereby increase sales productivity and inventory turnover.
 
  a. Efficient assortment
  b. Efficient product introductions
  c. Efficient replenishment
  d. Efficient promotions

Question 2

This initiative was designed to increase the success rate of new products by gathering and sharing among trading partners more accurate purchasing data on a timely basis.
 
  a. Efficient assortment
  b. Efficient product introductions
  c. Efficient replenishment
  d. Efficient promotions



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

aloop

  • Sr. Member
  • ****
  • Posts: 315
Answer to Question 1

A

Answer to Question 2

B





 

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

In 1885, the Lloyd Manufacturing Company of Albany, New York, promoted and sold "Cocaine Toothache Drops" at 15 cents per bottle! In 1914, the Harrison Narcotic Act brought the sale and distribution of this drug under federal control.

Did you know?

Liver spots have nothing whatsoever to do with the liver. They are a type of freckles commonly seen in older adults who have been out in the sun without sufficient sunscreen.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library